Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA BNP and NT-proBNP Market, by Location of Testing
1.4.2 LAMEA BNP and NT-proBNP Market, by Application
1.4.3 LAMEA BNP and NT-proBNP Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA BNP and NT-proBNP Market by Location of Testing
3.1 LAMEA Point of Care Testing Market by Country
3.2 LAMEA Laboratory Testing Market by Country
Chapter 4. LAMEA BNP and NT-proBNP Market by Application
4.1 LAMEA Myocardial Infarction Market by Country
4.2 LAMEA Acute Coronary Syndrome (ACS) Market by Country
4.3 LAMEA Congestive Heart Failure (CHF) Market by Country
4.4 LAMEA Others Market by Country
Chapter 5. LAMEA BNP and NT-proBNP Market by Country
5.1 Brazil BNP and NT-proBNP Market
5.1.1 Brazil BNP and NT-proBNP Market by Location of Testing
5.1.2 Brazil BNP and NT-proBNP Market by Application
5.2 Argentina BNP and NT-proBNP Market
5.2.1 Argentina BNP and NT-proBNP Market by Location of Testing
5.2.2 Argentina BNP and NT-proBNP Market by Application
5.3 UAE BNP and NT-proBNP Market
5.3.1 UAE BNP and NT-proBNP Market by Location of Testing
5.3.2 UAE BNP and NT-proBNP Market by Application
5.4 Saudi Arabia BNP and NT-proBNP Market
5.4.1 Saudi Arabia BNP and NT-proBNP Market by Location of Testing
5.4.2 Saudi Arabia BNP and NT-proBNP Market by Application
5.5 South Africa BNP and NT-proBNP Market
5.5.1 South Africa BNP and NT-proBNP Market by Location of Testing
5.5.2 South Africa BNP and NT-proBNP Market by Application
5.6 Nigeria BNP and NT-proBNP Market
5.6.1 Nigeria BNP and NT-proBNP Market by Location of Testing
5.6.2 Nigeria BNP and NT-proBNP Market by Application
5.7 Rest of LAMEA BNP and NT-proBNP Market
5.7.1 Rest of LAMEA BNP and NT-proBNP Market by Location of Testing
5.7.2 Rest of LAMEA BNP and NT-proBNP Market by Application
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.2 Siemens AG
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Danaher Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Gentian Diagnostics ASA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expenses
6.5 PerkinElmer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 BioMérieux S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Quidel Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Bio-Rad laboratories, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 F. Hoffmann-La Roche Ltd. (Roche Holding Ltd.)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.10. Scripps Laboratories
6.10.1 Company Overview
Unique Offerings 